首页 > 最新文献

Anaesthesia Critical Care & Pain Medicine最新文献

英文 中文
Are corticosteroids in intensive care immunosuppressive? Reflections and hypotheses.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-02-14 DOI: 10.1016/j.accpm.2025.101492
Rayan Braïk

This review reconsiders the classification of corticosteroids as immunosuppressants in the management of acute inflammatory conditions in critical care. Despite their widespread use in ARDS and septic shock, the association between corticosteroid therapy and increased infection risk remains contentious. By exploring alternative mechanisms and presenting new hypotheses, this review suggests that the traditional view of corticosteroids as immunosuppressants may be overly simplistic and context dependent.

{"title":"Are corticosteroids in intensive care immunosuppressive? Reflections and hypotheses.","authors":"Rayan Braïk","doi":"10.1016/j.accpm.2025.101492","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101492","url":null,"abstract":"<p><p>This review reconsiders the classification of corticosteroids as immunosuppressants in the management of acute inflammatory conditions in critical care. Despite their widespread use in ARDS and septic shock, the association between corticosteroid therapy and increased infection risk remains contentious. By exploring alternative mechanisms and presenting new hypotheses, this review suggests that the traditional view of corticosteroids as immunosuppressants may be overly simplistic and context dependent.</p>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101492"},"PeriodicalIF":3.7,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion thresholds after acute brain injury: How can they impact on protocols optimizing brain oxygenation?
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-02-06 DOI: 10.1016/j.accpm.2025.101491
Pierre Bouzat, Fabio Silvio Taccone
{"title":"Transfusion thresholds after acute brain injury: How can they impact on protocols optimizing brain oxygenation?","authors":"Pierre Bouzat, Fabio Silvio Taccone","doi":"10.1016/j.accpm.2025.101491","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101491","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101491"},"PeriodicalIF":3.7,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143374686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion strategy in the most critically patients with trauma brain injury: Differences to other populations?
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-02-05 DOI: 10.1016/j.accpm.2025.101490
Fabien Coisy, Florian Ajavon, Jeffrey Lipman, Jean-Yves Lefrant, Xavier Bobbia
{"title":"Transfusion strategy in the most critically patients with trauma brain injury: Differences to other populations?","authors":"Fabien Coisy, Florian Ajavon, Jeffrey Lipman, Jean-Yves Lefrant, Xavier Bobbia","doi":"10.1016/j.accpm.2025.101490","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101490","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101490"},"PeriodicalIF":3.7,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143374685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protecting the lungs during surgery: modes of ventilation are no silver bullet.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.accpm.2025.101488
Mauro Roberto Tucci, Sérgio Martins Pereira, Martin Girard
{"title":"Protecting the lungs during surgery: modes of ventilation are no silver bullet.","authors":"Mauro Roberto Tucci, Sérgio Martins Pereira, Martin Girard","doi":"10.1016/j.accpm.2025.101488","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101488","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101488"},"PeriodicalIF":3.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac surgery associated-acute kidney injury: deciphering renal physiology to understand effects of amino acids infusion.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-31 DOI: 10.1016/j.accpm.2025.101487
Timothée Ayasse, Quentin De Roux, Ali Jendoubi, Nicolas Mongardon
{"title":"Cardiac surgery associated-acute kidney injury: deciphering renal physiology to understand effects of amino acids infusion.","authors":"Timothée Ayasse, Quentin De Roux, Ali Jendoubi, Nicolas Mongardon","doi":"10.1016/j.accpm.2025.101487","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101487","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101487"},"PeriodicalIF":3.7,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143081713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing early mobilization in critically ill patients through multidisciplinary rounds: A process-focused observational study.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-30 DOI: 10.1016/j.accpm.2025.101485
Nobuhiro Shiota, Nobuyuki Nosaka, Nobutoshi Nawa, Takeo Fujiwara, Hidenobu Shigemitsu, Kenji Wakabayashi

Backgrounds: Early mobilization (EM) is vital for critically ill patients, yet various barriers hinder its implementation in daily critical care practice. This study aimed to explore the impact of multidisciplinary rounds (MDR) on the initiation of EM.

Methods: We conducted a retrospective, process-focused observational study in the medical/surgical intensive care unit (ICU) of a tertiary university medical center in Tokyo, Japan, including 301 patients who received physical therapy (PT) during their ICU stay. MDR implementation commenced in October 2016, followed by a year-long initiative to enhance awareness about the importance of EM. Patients admitted between April 2015 and September 2016 were categorized into the pre-MDR group (Phase 1, n = 110), while those admitted from October 2017 to March 2019 formed the post-MDR group (Phase 2, n = 191).

Results: EM practice was significantly increased in Phase 2, compared to Phase 1 (39.8% vs. 20.9%; p =  0.001), particularly among mechanically ventilated patients (33.8% vs. 9.3%; p <  0.001). The median time from ICU admission to PT initiation was significantly reduced in Phase 2 (3.0 vs. 6.0 days, p <  0.001). Additionally, PT consultations significantly increased from 9.2% to 16.5% (X2 = 27.75, p <  0.001). MDR was associated with an 84% higher likelihood of initiating EM (adjusted relative risk 1.84, 95% CI 1.30-2.61).

Conclusions: MDR played a pivotal role in enhancing the initiation of EM for ICU patients, highlighting its significance in overcoming barriers to EM.

{"title":"Enhancing early mobilization in critically ill patients through multidisciplinary rounds: A process-focused observational study.","authors":"Nobuhiro Shiota, Nobuyuki Nosaka, Nobutoshi Nawa, Takeo Fujiwara, Hidenobu Shigemitsu, Kenji Wakabayashi","doi":"10.1016/j.accpm.2025.101485","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101485","url":null,"abstract":"<p><strong>Backgrounds: </strong>Early mobilization (EM) is vital for critically ill patients, yet various barriers hinder its implementation in daily critical care practice. This study aimed to explore the impact of multidisciplinary rounds (MDR) on the initiation of EM.</p><p><strong>Methods: </strong>We conducted a retrospective, process-focused observational study in the medical/surgical intensive care unit (ICU) of a tertiary university medical center in Tokyo, Japan, including 301 patients who received physical therapy (PT) during their ICU stay. MDR implementation commenced in October 2016, followed by a year-long initiative to enhance awareness about the importance of EM. Patients admitted between April 2015 and September 2016 were categorized into the pre-MDR group (Phase 1, n = 110), while those admitted from October 2017 to March 2019 formed the post-MDR group (Phase 2, n = 191).</p><p><strong>Results: </strong>EM practice was significantly increased in Phase 2, compared to Phase 1 (39.8% vs. 20.9%; p =  0.001), particularly among mechanically ventilated patients (33.8% vs. 9.3%; p <  0.001). The median time from ICU admission to PT initiation was significantly reduced in Phase 2 (3.0 vs. 6.0 days, p <  0.001). Additionally, PT consultations significantly increased from 9.2% to 16.5% (X<sup>2</sup> = 27.75, p <  0.001). MDR was associated with an 84% higher likelihood of initiating EM (adjusted relative risk 1.84, 95% CI 1.30-2.61).</p><p><strong>Conclusions: </strong>MDR played a pivotal role in enhancing the initiation of EM for ICU patients, highlighting its significance in overcoming barriers to EM.</p>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101485"},"PeriodicalIF":3.7,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatic Stone Protein in patients with liver failure: a prospective pilot cohort study.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-30 DOI: 10.1016/j.accpm.2025.101486
Diogo Lopes, João Pedro Bandovas, Beatriz Chumbinho, Catarina Espírito Santo, Mónica Sousa, Bernardo Ferreira, Luis Val-Flores, Nuno Germano, Rui Pereira, Filipe S Cardoso, Luís Bento, Pedro Póvoa

Background: Pancreatic Stone Protein (PSP) seems to have higher accuracy for sepsis detection compared to other biomarkers. As PSP has never been studied in patients with liver failure (LF), our purpose was to assess its accuracy for diagnosis of infection and prognosis in this population.

Methods: We conducted a prospective pilot cohort study on patients with LF consecutively admitted to the Intensive Care Unit of a liver transplant center in 2021-2023. Ongoing overt infection was an exclusion criterion. Daily measurements of biomarkers were performed until discharge, death, or for 21 days. Analysis was performed by adjusting the baseline for the first infection episode (median on D3), which was the reference for those non-infected.

Results: Sixteen patients were included, 7 with acute and 9 with acute-on-chronic LF. Median age was 54 (interquartile range 42-64) years, half were female, with admission SOFA score of 10 (IQR 8-12). Hospital mortality was 43.8% (n = 7). An infection was observed in 8 patients, who presented non-significantly higher levels of PSP than non-infected ones during follow-up. Levels were higher in non-survivors than survivors (p < 0.05 from D4 on and since the day of infection considering only infected patients). Similarly, patients under renal replacement therapy had higher PSP levels than others (p < 0.05, D2 to D7 after admission).

Conclusion: This pilot study provides early insights into PSP kinetics, suggesting a potential role for prognosis in patients with LF. PSP rises in both ALF and ACLF to levels sustainably higher than those expected for healthy adults. Further research is needed to reassess its diagnostic accuracy for infection and redefine cut-offs in this population.

{"title":"Pancreatic Stone Protein in patients with liver failure: a prospective pilot cohort study.","authors":"Diogo Lopes, João Pedro Bandovas, Beatriz Chumbinho, Catarina Espírito Santo, Mónica Sousa, Bernardo Ferreira, Luis Val-Flores, Nuno Germano, Rui Pereira, Filipe S Cardoso, Luís Bento, Pedro Póvoa","doi":"10.1016/j.accpm.2025.101486","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101486","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic Stone Protein (PSP) seems to have higher accuracy for sepsis detection compared to other biomarkers. As PSP has never been studied in patients with liver failure (LF), our purpose was to assess its accuracy for diagnosis of infection and prognosis in this population.</p><p><strong>Methods: </strong>We conducted a prospective pilot cohort study on patients with LF consecutively admitted to the Intensive Care Unit of a liver transplant center in 2021-2023. Ongoing overt infection was an exclusion criterion. Daily measurements of biomarkers were performed until discharge, death, or for 21 days. Analysis was performed by adjusting the baseline for the first infection episode (median on D3), which was the reference for those non-infected.</p><p><strong>Results: </strong>Sixteen patients were included, 7 with acute and 9 with acute-on-chronic LF. Median age was 54 (interquartile range 42-64) years, half were female, with admission SOFA score of 10 (IQR 8-12). Hospital mortality was 43.8% (n = 7). An infection was observed in 8 patients, who presented non-significantly higher levels of PSP than non-infected ones during follow-up. Levels were higher in non-survivors than survivors (p < 0.05 from D4 on and since the day of infection considering only infected patients). Similarly, patients under renal replacement therapy had higher PSP levels than others (p < 0.05, D2 to D7 after admission).</p><p><strong>Conclusion: </strong>This pilot study provides early insights into PSP kinetics, suggesting a potential role for prognosis in patients with LF. PSP rises in both ALF and ACLF to levels sustainably higher than those expected for healthy adults. Further research is needed to reassess its diagnostic accuracy for infection and redefine cut-offs in this population.</p>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101486"},"PeriodicalIF":3.7,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative delirium after cardiac surgery associated with perioperative gut microbiota dysbiosis: Evidence from human and antibiotic-treated mouse model.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-23 DOI: 10.1016/j.accpm.2025.101484
Peiying Huang, Lichao Di, Sichen Cui, Xueji Wang, Tianyu Cao, Sufang Jiang, Lining Huang

Background: Research links gut microbiota to postoperative delirium (POD) through the gut-brain axis. However, changes in gut microbiota and fecal short-chain fatty acids (SCFAs) in POD patients during the perioperative period and their association with POD are unclear.

Methods: We conducted a nested case-control study among patients undergoing off-pump coronary artery bypass grafting, focusing on POD as the main outcome. POD patients were matched 1:1 with non-POD patients based on sociodemographic characteristics, health, and diet. Fecal samples were collected pre- and post-surgery to assess gut microbiota and SCFA changes. Postoperative fecal samples were transplanted into antibiotic-treated mice to evaluate delirium-like behavior and neuroinflammation.

Results: Out of 120 patients, 60 were matched. Before surgery, gut microbiota in both groups was similar. After surgery, POD patients had lower alpha diversity and distinct microbiota compared to non-POD patients. LEfSe analysis showed POD was linked to increased opportunistic pathogens (Enterococcus) and decreased SCFA producers (Bacteroides, Ruminococcus, etc.). SCFAs were significantly reduced in POD patients and negatively correlated with delirium severity and plasma inflammation. Mice receiving fecal transplants from POD patients exhibited delirium-like behavior and neuroinflammation.

Conclusions: Postoperative delirium is associated with gut microbiota dysbiosis, marked by an increase in opportunistic pathogens and a decrease in SCFA-producing genera.

Registration: Chinese Clinical Trial Registry ChiCTR2300070477.

{"title":"Postoperative delirium after cardiac surgery associated with perioperative gut microbiota dysbiosis: Evidence from human and antibiotic-treated mouse model.","authors":"Peiying Huang, Lichao Di, Sichen Cui, Xueji Wang, Tianyu Cao, Sufang Jiang, Lining Huang","doi":"10.1016/j.accpm.2025.101484","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101484","url":null,"abstract":"<p><strong>Background: </strong>Research links gut microbiota to postoperative delirium (POD) through the gut-brain axis. However, changes in gut microbiota and fecal short-chain fatty acids (SCFAs) in POD patients during the perioperative period and their association with POD are unclear.</p><p><strong>Methods: </strong>We conducted a nested case-control study among patients undergoing off-pump coronary artery bypass grafting, focusing on POD as the main outcome. POD patients were matched 1:1 with non-POD patients based on sociodemographic characteristics, health, and diet. Fecal samples were collected pre- and post-surgery to assess gut microbiota and SCFA changes. Postoperative fecal samples were transplanted into antibiotic-treated mice to evaluate delirium-like behavior and neuroinflammation.</p><p><strong>Results: </strong>Out of 120 patients, 60 were matched. Before surgery, gut microbiota in both groups was similar. After surgery, POD patients had lower alpha diversity and distinct microbiota compared to non-POD patients. LEfSe analysis showed POD was linked to increased opportunistic pathogens (Enterococcus) and decreased SCFA producers (Bacteroides, Ruminococcus, etc.). SCFAs were significantly reduced in POD patients and negatively correlated with delirium severity and plasma inflammation. Mice receiving fecal transplants from POD patients exhibited delirium-like behavior and neuroinflammation.</p><p><strong>Conclusions: </strong>Postoperative delirium is associated with gut microbiota dysbiosis, marked by an increase in opportunistic pathogens and a decrease in SCFA-producing genera.</p><p><strong>Registration: </strong>Chinese Clinical Trial Registry ChiCTR2300070477.</p>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101484"},"PeriodicalIF":3.7,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143042641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual reality for reduction of intraprocedural pharmacological sedation and analgesia in adult patients: A systematic review and meta-analysis
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-23 DOI: 10.1016/j.accpm.2025.101483
Joe Zako , Nicolas Daccache , Louis Morisson , Philippe Richebé , Pascal Laferrière-Langlois

Background

Pharmacological sedation and analgesia are used to alleviate discomfort during awake medical procedures but can cause adverse effects like apnea and hypoxemia, increasing the need for airway management and prolonging recovery. Virtual reality (VR) has emerged as a non-pharmacological intervention to reduce the need for procedural sedatives and analgesics.

Methods

A systematic review and meta-analysis were conducted, assessing the impact of VR immersion on intraprocedural sedation and analgesia usage in adults (≥ 18 years). We searched MEDLINE (PubMed), Embase, Cochrane CENTRAL, and Web of Science from inception to August 1st, 2024. We included analytical studies utilizing VR immersion in the intervention arm, and reporting tailored dosages of intraprocedural sedatives (propofol, midazolam) and/or opioids. Statistical analyses used standardized mean differences (SMD), and heterogeneity was assessed with I2.

Results

Of 2714 identified papers, 11 (560 patients) were included. VR significantly reduced propofol usage (SMD = −1.70; 95% CI −3.10 to −0.31; P = 0.02; I2 = 92%) and midazolam usage (SMD = −0.29; 95% CI −0.57 to 0.00; P = 0.05; I2 = 0%). However, our analysis showed no reduction in opioid usage (SMD = −0.21; 95% CI −0.60 to 0.19; P = 0.31; I2 = 74%) in the VR group.

Conclusions

VR immersion effectively reduces the required dose of intraprocedural sedatives, but its impact on opioid consumption remains unclear, especially in the absence of regional or neuraxial anesthesia. Further research is needed to clarify these effects and optimize VR use in clinical practice.

Registration

This review’s protocol was prospectively registered on PROSPERO (CRD42024569462).
{"title":"Virtual reality for reduction of intraprocedural pharmacological sedation and analgesia in adult patients: A systematic review and meta-analysis","authors":"Joe Zako ,&nbsp;Nicolas Daccache ,&nbsp;Louis Morisson ,&nbsp;Philippe Richebé ,&nbsp;Pascal Laferrière-Langlois","doi":"10.1016/j.accpm.2025.101483","DOIUrl":"10.1016/j.accpm.2025.101483","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacological sedation and analgesia are used to alleviate discomfort during awake medical procedures but can cause adverse effects like apnea and hypoxemia, increasing the need for airway management and prolonging recovery. Virtual reality (VR) has emerged as a non-pharmacological intervention to reduce the need for procedural sedatives and analgesics.</div></div><div><h3>Methods</h3><div>A systematic review and meta-analysis were conducted, assessing the impact of VR immersion on intraprocedural sedation and analgesia usage in adults (≥ 18 years). We searched MEDLINE (PubMed), Embase, Cochrane CENTRAL, and Web of Science from inception to August 1st, 2024. We included analytical studies utilizing VR immersion in the intervention arm, and reporting tailored dosages of intraprocedural sedatives (propofol, midazolam) and/or opioids. Statistical analyses used standardized mean differences (SMD), and heterogeneity was assessed with I<sup>2</sup>.</div></div><div><h3>Results</h3><div>Of 2714 identified papers, 11 (560 patients) were included. VR significantly reduced propofol usage (SMD = −1.70; 95% CI −3.10 to −0.31; <em>P</em> = 0.02; I<sup>2</sup> = 92%) and midazolam usage (SMD = −0.29; 95% CI −0.57 to 0.00; <em>P</em> = 0.05; I<sup>2</sup> = 0%). However, our analysis showed no reduction in opioid usage (SMD = −0.21; 95% CI −0.60 to 0.19; <em>P</em> = 0.31; I<sup>2</sup> = 74%) in the VR group.</div></div><div><h3>Conclusions</h3><div>VR immersion effectively reduces the required dose of intraprocedural sedatives, but its impact on opioid consumption remains unclear, especially in the absence of regional or neuraxial anesthesia. Further research is needed to clarify these effects and optimize VR use in clinical practice.</div></div><div><h3>Registration</h3><div>This review’s protocol was prospectively registered on PROSPERO (CRD42024569462).</div></div>","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":"44 2","pages":"Article 101483"},"PeriodicalIF":3.7,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143042576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change in femoral artery pulsatility index as a novel predictor of post-spinal anesthesia hypotension in adult patients undergoing infra-umbilical surgeries: A prospective observational study.
IF 3.7 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2025-01-21 DOI: 10.1016/j.accpm.2025.101482
Mina Adolf Helmy, Mahmoud Mansour, Lydia Magdy Milad, Esmat Mohammed Aboelregal, Marianne Magdy Youssef
{"title":"Change in femoral artery pulsatility index as a novel predictor of post-spinal anesthesia hypotension in adult patients undergoing infra-umbilical surgeries: A prospective observational study.","authors":"Mina Adolf Helmy, Mahmoud Mansour, Lydia Magdy Milad, Esmat Mohammed Aboelregal, Marianne Magdy Youssef","doi":"10.1016/j.accpm.2025.101482","DOIUrl":"https://doi.org/10.1016/j.accpm.2025.101482","url":null,"abstract":"","PeriodicalId":48762,"journal":{"name":"Anaesthesia Critical Care & Pain Medicine","volume":" ","pages":"101482"},"PeriodicalIF":3.7,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anaesthesia Critical Care & Pain Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1